{
  "trial_id": "NCT00999804",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "female",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "age >= 18",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "signed informed consent",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "locally advanced breast cancer",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "tumor size > 3 cm or clinical evidence of axillary nodal involvement",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "histologically confirmed invasive mammary carcinoma that is HER2 overexpressing",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "negative serum pregnancy test within 7 days of starting study drug",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "kidney and liver function tests within 1.5 times the institutional upper limit of normal",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "performance status (WHO/ECOG scale) 0-1 and life expectancy >6 months",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "no evidence of brain or leptomeningeal disease, or any other Stage IV disease",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "no previous or current malignancies at other sites within the last 5 years",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "adequately treated cone-biopsied in situ carcinoma of the cervix uteri and basal or squamous cell carcinoma of the skin",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "bilateral breast cancer",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "pregnancy or unwillingness to use a reliable contraceptive method in women of child-bearing potential",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "severe underlying chronic illness or disease",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "cardiomyopathy or baseline LVEF less than 50%",
      "label": "triggers",
      "evidence": "unknown"
    }
  ],
  "notes": "45-year-old postmenopausal woman with cytologically confirmed breast cancer, HER2-positive and ER/PR negative. Axillary sampling revealed 5 positive lymph nodes.",
  "_meta": {
    "topic_id": "61",
    "trial_id": "NCT00999804",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}